<DOC>
	<DOCNO>NCT00427050</DOCNO>
	<brief_summary>The purpose study determine optimal tolerate regime PEP005 treatment actinic keratoses face face scalp .</brief_summary>
	<brief_title>A Study Determine Optimal Tolerated Regime Safety PEP005 Topical Gel</brief_title>
	<detailed_description>Actinic keratoses ( AK ) common skin condition characterize rough , scaly patch sores top layer skin leave untreated progress skin cancer . Current treatment cause scar hypopigmentation , inconvenient , require long treatment duration . Non-invasive alternative therapy treatment AK lesion thus research .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>1 . Male patient least 18 year age . 2 . Postmenopausal female patient i.e. , menses least 12 consecutive month , without uterus . 3 . Four eight clinically typical , visible discrete AK lesion within contiguous 25 cm2 treatment area face face scalp . 5 . Ability follow study instruction likely complete study requirement . 6 . Written inform consent obtain . 7 . Agreement patient allow photograph select AK treatment area take used part study data package .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Actinic Keratoses ( AK )</keyword>
	<keyword>PEP005</keyword>
	<keyword>Topical</keyword>
	<keyword>Dermatology</keyword>
</DOC>